2 completed, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Bugra Kerget: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Respiratory and Peripheral Muscle Strength as Predictors of Inhaler Treatment Response in Asthma: A Comparison of DPI and MDI Devices MDI Inhaler Therapy, DPI Inhaler Therapy - Asthma (Diagnosis) | Not applicable | Completed | Bugra Kerget | 80 | 2025-03-01 | 2025-11-18 |
| Effectiveness of IMT/PEP Therapy in Group E COPD and Comparison of GOLD vs STAR Classifications Inspiratory Muscle Training / Positive Expiratory Pressure (IMT/PEP) Therapy - COPD, Inspiratory Muscle Training | Completed | Bugra Kerget | 61 | 2023-06-01 | 2025-09-24 | |
| Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19 Standart treatment group, Montelukast sodium 10 mg treatment, Montelukast sodium 20 mg treatment - COVID-19 Pneumonia | Phase 4 | Unknown | Bugra Kerget | 180 | 2021-10-22 | 2021-10-26 |
Asthma (1) · Disease (1) · Pulmonary Disease, Chronic Obstructive (1)
Therapeutics (2) · montelukast (1)
Turkey (Türkiye) (3)